On July 22, Northrop Grumman rose 3.04% in regular trading, trading at $528.4/share, with turnover of $37.48 million. The stock rebounded as the market digested the full picture of the Q2 earnings report released on July 21, which had initially triggered a decline of over 5%.

While Q2 adjusted EPS of $6.77 narrowly missed the consensus estimate of $6.82, the quarter featured significant positives: GAAP EPS of $7.68 exceeded the FactSet estimate of $6.84, net awards surged to over $20 billion with total backlog reaching $105 billion, and sales of $10.88 billion beat the $10.80 billion estimate. The company also raised its full-year sales guidance to $43.75B-$44.25B, in line with consensus.

On the analyst front, Deutsche Bank trimmed its price target to $615 from $645 while maintaining a Buy rating, following RBC's cut to $640 from $750 on July 21. The average analyst price target stands at $648.80 with an overweight consensus rating, suggesting the prior session's sell-off was an overreaction relative to the robust order momentum and upgraded outlook.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)